Inactivation of the anticancer drugs doxorubicin and oracin by aldo-keto reductase (AKR) 1C3

Abstrakt

In the present study, we produced recombinant AKR1C3 and provided evidence that this AKR1C3 member catalyzes the inactivation of oracin and doxorubicin with high efficiency